Third shedding phase on less than 6 months of treatment Chat 5/24/2026
The user has been using minoxidil for almost 6 months and finasteride for almost 4 months, experiencing significant shedding and minimal stabilization. They are considering switching to dutasteride if no improvements are seen and are advised to be patient, as results may take up to 2 years.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity My 1.5-year journey: Transitioning from Finasteride/Topical to Dutasteride + Oral Minoxidil (5mg)
The user transitioned from finasteride and topical minoxidil to dutasteride and oral minoxidil, increasing the oral minoxidil dose to 5mg, which led to shedding but also new hair growth. They found oral treatments more effective and convenient, despite initial shedding, and are seeking advice on long-term results and experiences with similar transitions.
community Roughly 3 years Finateride monotherapy. 25M
A 25-year-old male has been using finasteride since October 2022 to combat diffuse thinning and hairline recession, experiencing initial shedding but later stabilization. He plans to add oral minoxidil to improve hair density and is open to trying dutasteride if necessary, with minimal side effects reported.
community 12 months of Fin + minox + microneedling, still shedding, no regrowth
The user experienced significant hair shedding and no regrowth despite using Minoxidil, Finasteride, and microneedling for 12 months. They are considering switching to Dutasteride due to ongoing hair loss issues.
community Summed up version of my hair loss journey so far
The user started a hair loss treatment with oral minoxidil, topical finasteride, and microneedling, later switching to oral finasteride and topical minoxidil. Despite initial stabilization, shedding resumed, and the user is considering switching to dutasteride after 12 months.
community I started thing on the crown after 3 months on fin - M19
A 19-year-old is experiencing crown thinning after three months on finasteride and minoxidil, hoping it's just a shedding phase. They also use a dermaroller weekly and seek hair regrowth and stabilization.
Related Research
6 / 6 resultsresearch P166 Real-world efficacy and tolerability of oral dutasteride combined with oral minoxidil for male androgenetic alopecia: a retrospective cohort study
This study found that in men with androgenetic alopecia, a combination therapy of oral dutasteride and minoxidil was well tolerated and resulted in hair stabilization for nearly all participants by month 6, with 71.4% showing improvement by month 9.
research Injectable Therapy for Androgenetic Alopecia: A Systematic Review
In this systematic review, researchers found that injectable therapies, including agents like dutasteride and multivitamin formulations, may offer cosmetic benefits for androgenetic alopecia; however, evidence is limited by small study sizes, varied methods, and short follow-up periods, necessitating standardized trials for routine use recommendations.
research The Use of Oral Dutasteride, Minoxidil, and Finasteride for Treating Endocrine Therapy-Induced Hair Loss from Breast Cancer Treatment: A Case Series Study
Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.
research Nonsurgical Therapy for Hair Loss
This review discusses current and emerging medical therapies for androgenetic alopecia but reports no new clinical findings, emphasizing the importance of stabilizing the condition as a complement to surgical hair restoration.
research Phytochemicals as emerging therapeutic agents for alopecia treatment
This chapter provides an overview of phytochemicals with properties to combat alopecia and discusses the potential of flavonoids, found in several herbs, as a safer alternative to synthetic hair loss treatments due to their long-term skin compatibility.
research Pattern Hair Loss in Men
This article reviews current knowledge on the causes, diagnosis, and medical treatments for androgenetic alopecia, particularly in men, and reports no new findings.